期刊文献+

不同糖调节受损人群胰岛β细胞功能和胰岛素反应敏感性评估的意义 被引量:5

Evaluation of islet β-cell-function and insulin response sensitivity in individuals with different impaired glucose regulation
下载PDF
导出
摘要 目的探讨不同糖调节受损人群β细胞胰岛素分泌功能(β细胞功能)损害和胰岛素抵抗(IR)的特点,为糖尿病的一级预防提供理论依据。方法根据口服75 g葡萄糖耐量试验将200例研究对象分为:正常糖耐量(NGT)组37例;单纯空腹血糖受损(I-IFG)组35例;单纯糖耐量受损(I-IGT)组50例;混合糖调节受损(CGI)组33例;新诊断2型糖尿病(N2DM)组45例。采用HOMA-β和HOMA-IR评价基础β细胞功能和基础IR,△I30/△G30、△I60/△G60和△I120/△G120分别评价糖负荷后的早相和晚相β细胞功能,胰岛素敏感性指数(SIM)评价外周胰岛素反应敏感性。结果与NGT组比较,I-IFG组HOMA-β和△I30/△G30明显降低(均P<0.01),而HOMA-IR明显升高(P<0.01),两组间△I60/△G60、△I120/△G120和SIM无明显差异;I-IGT组△I30/△G30、△I60/△G60、△I120/△G120和SIM明显降低(P<0.05或P<0.01),而HOMA-β和HOMA-IR与NGT组无明显差异;CGI组HOMA-β、△I30/△G30、△I60/△G60、△I120/△G120和SIM均明显降低(P<0.05或P<0.01),而HOMA-IR明显升高(P<0.01);与N2DM组比较,I-IFG组、CGI组和I-IGT组HOMA-β均明显高于N2DM组(P<0.01),三组HOMA-IR均低于N2DM组(P<0.01),而△I30/△G30、△I60/△G60、△I120/△G120和SIM均高于N2DM组(均P<0.01)。结论 I-IFG人群主要为基础β细胞功能损害和基础IR增强,I-IGT人群以糖负荷后的早相和晚相胰岛素分泌功能缺陷以及外周胰岛素反应敏感性降低为主,而CGI人群则兼有基础和糖负荷后β细胞功能损害以及系统性IR增强。 [ Objective ] To investigate the characteristic of damaged islet β cell secretion insulin function (β-cell- function) and insulin resistance (IR) in individuals with different impaired glucose regulation, to provide theoretic foundation for first-degree prevention of diabetes mellitus. [Methods] According to oral 75 g glucose tolerance test (OGTT), 200 subjects were divided into normal glucose tolerance (NGT, n =37), isolated-impaired fasting glu- cose (I-IFG, n =35), isolated-impaired glucose tolerance (I-IGT, n =50), combined glucose intolerance (CGI, n=33) and newly diagnosis type 2 diabetes mellitus (N2DM, n =45). HOMA-β and HOMA-IR were applied to assess the basic β-cell-function and basic IR, the ratio of insulin increment from 0 min to 30 min, 60 rain and 120 rain to that of blood glucose from 0 rain to 30 min, 60 min and 120 min (△I30/△G30, △I60/AG60 and△I120/△G120) were used to evaluate the early phase and_the late phase β-cell-function respectively, and SIM was adopted to evaluate the pc-ripheral tissue insulin sensitivity. [Results] As compared with NGT group,in I-IFG group,HOMA-β and △I30/ △G30 were lower (all P 〈0.01), HOMA-IR was higher (P 〈0.01), while △I60/△G60,△I120/△G120 and SIM were no difference; in I-IGT group, △I30/△G30, △I60/△G60,△I120/△G120 and SIM were lower (P 〈0.05 or P 〈0.01), HOMA- and HOMA- IR were no difference; in CGI group, HOMA-β, △I30/△G30, △I60/△G60,△I120/△G120 and SIM were lower (P 〈0.05 or P 〈0.01), and HOMA-IR was higher (P 〈0.01), as compared with N2DM group, HOMA-15 was marked higher in I-IFG, I-IGT and CGI groups (all P 〈0.01); while △I30/△G30, △I60/△G60,△I120/△G120 and SIM were marked higher (all P 〈0.01), and HOMA-IR was marked lower (P 〈0.01) in three group. [ Conclusions] The individuals with I-IFG mainly showed damaged of basic β-cell-function and enhancement of basic IR, the individ- uals with I-IGT showed 15 cell secretion insulin function defect of all early and late phase during glucose load and reduction of the peripheral tissue insulin sensitivity, the individuals with CGI had dysfunction of basic and postprandial β-cell-function as well as enhancement of system IR, while the patients with N2DM in degree of im- paired β-cell- function and IR were more severe than individuals with IGR.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第21期18-22,共5页 China Journal of Modern Medicine
关键词 胰岛Β细胞功能 胰岛素抵抗 糖调节受损 islet β-cell-function insulin resistance impaired glucose regulation
  • 相关文献

参考文献4

二级参考文献86

  • 1Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study. Diabetes Care, 1997,20:1087-1092.
  • 2Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: comparison of glucose of insulin resistance and secretion. Diabet Med , 1994,11:286-292.
  • 3Defronzo RA, Ferrannini E, Simensen DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus, contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism, 1989,38:387-395.
  • 4Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic β-cell dysfuction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA, 1995,273:1855-1861.
  • 5Melchionda N, Forlani G, Marchesini G, et al. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obes Relat Metab Disord, 200
  • 6Li CL, Tsai ST, Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study. J Clin Epidemiol, 2002,55:19-24.
  • 7Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes, 1999,48:2197-2203.
  • 8Davies MJ, Raymond NT, Day JH, et al. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med, 2000,17:433-440.
  • 9Unger RH, Faster DW, Diabetes mellitus. In: Wilson JD, et al (eds). Williams textbook of endocrinology. 9th ed. Philadelphia: Saunders, 2001,1008-1009.
  • 10Cerasi E: Potentiation of insulin release by glucose in man. III. Different sensitivities of the pancreas to the initiating and the potentiating actions of glucose in diabetic and prediabetic subjects. Acta Endocr (Copenh.), 1975,79:511-534.

共引文献198

同被引文献48

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部